Painless Artificial Abortion Anesthesia
Conditions
Interventions
Five doses groups:Remifentanil
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. patients who had painless abortion in the First Affiliated Hospital of Chongqing Medical University from July 1, 2019 to July 1, 2020 and voluntarily participated in the study and signed the informed consent; 2. patients who were unwilling to continue pregnancy within three months and voluntarily chose painless abortion to end pregnancy; 3. patients who had no morbid obesity or serious basic diseases and ASA grade II or above.
Exclusion criteria
Exclusion criteria: 1. patients with contraindications to anesthesia (allergic constitution, allergic asthma, anesthetics and multi drug allergy) or contraindications to surgery (patients with poor physical condition, difficult to suffer from surgery and anesthesia, or in the acute stage of various diseases, or suffering from genital inflammation); 2. patients without fasting or drinking before surgery; 3. patients with mental diseases, communication problems; 4. preoperative for some reason Long term use of analgesics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative movement and its corresponding level; | — |
Countries
China
Contacts
Public ContactLiu Danyan
Department of Anesthesiology, the First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed